Press Releases by "Shionogi & Co., Ltd."

• Shionogi and Shire to Collaborate on the Development and Commercialization of the Therapeutic Agents for Attention-Deficit/Hyperactivity Disorder
  [ Pharmaceuticals | 2011-11-18]
• Result of a General Offer for China-based C&O Pharmaceutical Technology (Holdings) Limited
  [ Pharmaceuticals | 2011-10-13]
• Shionogi Receives National Health Insurance Drug Price Listing for Carbapenem-Type Antibiotic, gFinibax® 0.5g for Intravenous Drip Infusionh
  [ Pharmaceuticals | 2011-09-22]
• Shionogi & Co., Ltd. to Commence a General Offer for China-based C&O Pharmaceutical Technology (Holdings) Limited
  [ Pharmaceuticals | 2011-08-31]
• Shionogi & Co., Ltd. to Acquire the Shares and to Conduct a General Offer for China-based C&O Pharmaceutical Technology (Holdings) Limited
  [ Pharmaceuticals | 2011-08-18]
• Completion of New Pharmaceutical Research Building
  [ Pharmaceuticals | 2011-08-04]
• Shionogi Inc. Signs Agreement to Expand its Portfolio with Acquisition of Nine Marketed Products From Victory Pharma, Inc.
  [ Pharmaceuticals | 2011-07-19]
• License Agreement for the Sale of Pirfenidone (Pirespa®) in South Korea with ILDONG PHARMACEUTICAL
  [ Pharmaceuticals | 2011-07-12]
• Shionogi to Introduce Stock Options as Compensation (Stock Acquisition Rights) to Members of Board of Directors
  [ Pharmaceuticals | 2011-05-09]
• Shionogi Receives Approval of Additional Dosage and Administration of Carbapenem Antibiotic Products: Finibax® 0.25g IV Solution and Finibax® 0.25g IV Solution Kit
  [ Pharmaceuticals | 2011-04-22]
• Impact of the 2011 Great Eastern Japan Earthquake (3rd Report)
  [ Pharmaceuticals | 2011-04-04]
• Shionogi Signs Agreement with Denmark on International Industry-Academic Collaboration Initiatives
  [ Pharmaceuticals | 2011-04-01]
• Impact of the 2011 off the Pacific coast of Tohoku Earthquake (2nd Report)
  [ Pharmaceuticals | 2011-03-16]
• Impact of the 2011 off the Pacific coast of Tohoku Earthquake
  [ Pharmaceuticals | 2011-03-15]
• Shionogi-ViiV Healthcare Starts Phase III Trial for "572-Trii" Fixed-Dose Combination HIV Therapy
  [ Pharmaceuticals | 2011-02-03]
• Outsourcing Agreement on Distribution Operation
  [ Pharmaceuticals | 2011-01-31]
• Dissolution of a Consolidated Subsidiary
  [ Pharmaceuticals | 2011-01-31]
• Shionogi to enter into licensing agreement on NF-kappaB Decoy Oligodeoxynucleotide for Atopic Dermatitis with AnGes MG, Inc.
  [ Pharmaceuticals | 2010-12-27]
• Shionogi has entered into a licensing agreement on peptide vaccines for ophthalmic disease with OncoTherapy Science, Inc.
  [ Pharmaceuticals | 2010-12-06]
• Shionogi to make its subsidiary into a wholly owned subsidiary, and to change the corporate name
  [ Pharmaceuticals | 2010-11-01]

Most Popular: "Shionogi & Co., Ltd."